PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy5 anti-human CD11c, 25 tests
PE/Cy5 anti-human CD123, 100 tests
PE/Cy5 anti-human CD127 (IL-7Rα), 100 tests
PE/Cy5 anti-human CD127 (IL-7Rα), 25 tests
PE/Cy5 anti-human CD135 (Flt-3/Flk-2), 100 tests
PE/Cy5 anti-human CD137 (4-1BB), 100 tests
PE/Cy5 anti-human CD15 (SSEA-1), 100 tests
PE/Cy5 anti-human CD15 (SSEA-1), 25 tests
PE/Cy5 anti-human CD154, 100 tests
PE/Cy5 anti-human CD16, 100 tests
PE/Cy5 anti-human CD16, 25 tests
PE/Cy5 anti-human CD172a/b (SIRPα/β), 100 tests
PE/Cy5 anti-human CD172a/b (SIRPα/β), 25 tests
PE/Cy5 anti-human CD18, 25 tests
PE/Cy5 anti-human CD181 (CXCR1), 100 tests
PE/Cy5 anti-human CD184 (CXCR4), 100 tests